We partner with the media to inform the public of the global human crisis.
September 15, 2017Indivior Asserts New Patent Against ANDA Filers...
September 1, 2017Indivior Responds To Court Rulings in ANDA Litigation and Announces Intention To Appeal...
August 22, 2017Indivior Opens $30 Million Research and Development Center to Advance Treatment Innovation ...
July 31, 2017Indivior RBP-6000 NDA Acceptance with Priority Review Designation...
July 31, 2017Indivior’s NALSCUE® Receives Marketing Authorization from French Regulatory Agency ANSM...
Global Media Contacts
EMEA, Australasia and China Financial Disclosure Reporting
Disclosure Of Payments, Donations & Joint Working
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline